Literature DB >> 28167394

Deep ensemble learning of sparse regression models for brain disease diagnosis.

Heung-Il Suk1, Seong-Whan Lee2, Dinggang Shen3.   

Abstract

Recent studies on brain imaging analysis witnessed the core roles of machine learning techniques in computer-assisted intervention for brain disease diagnosis. Of various machine-learning techniques, sparse regression models have proved their effectiveness in handling high-dimensional data but with a small number of training samples, especially in medical problems. In the meantime, deep learning methods have been making great successes by outperforming the state-of-the-art performances in various applications. In this paper, we propose a novel framework that combines the two conceptually different methods of sparse regression and deep learning for Alzheimer's disease/mild cognitive impairment diagnosis and prognosis. Specifically, we first train multiple sparse regression models, each of which is trained with different values of a regularization control parameter. Thus, our multiple sparse regression models potentially select different feature subsets from the original feature set; thereby they have different powers to predict the response values, i.e., clinical label and clinical scores in our work. By regarding the response values from our sparse regression models as target-level representations, we then build a deep convolutional neural network for clinical decision making, which thus we call 'Deep Ensemble Sparse Regression Network.' To our best knowledge, this is the first work that combines sparse regression models with deep neural network. In our experiments with the ADNI cohort, we validated the effectiveness of the proposed method by achieving the highest diagnostic accuracies in three classification tasks. We also rigorously analyzed our results and compared with the previous studies on the ADNI cohort in the literature.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Convolutional neural network; Deep ensemble learning; Sparse regression model

Mesh:

Year:  2017        PMID: 28167394      PMCID: PMC5808465          DOI: 10.1016/j.media.2017.01.008

Source DB:  PubMed          Journal:  Med Image Anal        ISSN: 1361-8415            Impact factor:   8.545


  46 in total

1.  Identifying AD-sensitive and cognition-relevant imaging biomarkers via joint classification and regression.

Authors:  Hua Wang; Feiping Nie; Heng Huang; Shannon Risacher; Andrew J Saykin; Li Shen
Journal:  Med Image Comput Comput Assist Interv       Date:  2011

2.  Geodesic estimation for large deformation anatomical shape averaging and interpolation.

Authors:  Brian Avants; James C Gee
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

3.  A novel framework for longitudinal atlas construction with groupwise registration of subject image sequences.

Authors:  Shu Liao; Hongjun Jia; Guorong Wu; Dinggang Shen
Journal:  Neuroimage       Date:  2011-08-22       Impact factor: 6.556

4.  Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database.

Authors:  Rémi Cuingnet; Emilie Gerardin; Jérôme Tessieras; Guillaume Auzias; Stéphane Lehéricy; Marie-Odile Habert; Marie Chupin; Habib Benali; Olivier Colliot
Journal:  Neuroimage       Date:  2010-06-11       Impact factor: 6.556

Review 5.  Machine learning and radiology.

Authors:  Shijun Wang; Ronald M Summers
Journal:  Med Image Anal       Date:  2012-02-23       Impact factor: 8.545

6.  Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population.

Authors:  Chris Hinrichs; Vikas Singh; Guofan Xu; Sterling C Johnson
Journal:  Neuroimage       Date:  2010-12-10       Impact factor: 6.556

7.  Non-diffeomorphic registration of brain tumor images by simulating tissue loss and tumor growth.

Authors:  Evangelia I Zacharaki; Cosmina S Hogea; Dinggang Shen; George Biros; Christos Davatzikos
Journal:  Neuroimage       Date:  2009-07-01       Impact factor: 6.556

8.  Alzheimer's disease risk assessment using large-scale machine learning methods.

Authors:  Ramon Casanova; Fang-Chi Hsu; Kaycee M Sink; Stephen R Rapp; Jeff D Williamson; Susan M Resnick; Mark A Espeland
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.

Authors:  Daniel Schmitter; Alexis Roche; Bénédicte Maréchal; Delphine Ribes; Ahmed Abdulkadir; Meritxell Bach-Cuadra; Alessandro Daducci; Cristina Granziera; Stefan Klöppel; Philippe Maeder; Reto Meuli; Gunnar Krueger
Journal:  Neuroimage Clin       Date:  2014-11-08       Impact factor: 4.881

10.  Deep learning for neuroimaging: a validation study.

Authors:  Sergey M Plis; Devon R Hjelm; Ruslan Salakhutdinov; Elena A Allen; Henry J Bockholt; Jeffrey D Long; Hans J Johnson; Jane S Paulsen; Jessica A Turner; Vince D Calhoun
Journal:  Front Neurosci       Date:  2014-08-20       Impact factor: 4.677

View more
  31 in total

1.  Wilson disease tissue classification and characterization using seven artificial intelligence models embedded with 3D optimization paradigm on a weak training brain magnetic resonance imaging datasets: a supercomputer application.

Authors:  Mohit Agarwal; Luca Saba; Suneet K Gupta; Amer M Johri; Narendra N Khanna; Sophie Mavrogeni; John R Laird; Gyan Pareek; Martin Miner; Petros P Sfikakis; Athanasios Protogerou; Aditya M Sharma; Vijay Viswanathan; George D Kitas; Andrew Nicolaides; Jasjit S Suri
Journal:  Med Biol Eng Comput       Date:  2021-02-05       Impact factor: 2.602

Review 2.  Machine learning studies on major brain diseases: 5-year trends of 2014-2018.

Authors:  Koji Sakai; Kei Yamada
Journal:  Jpn J Radiol       Date:  2018-11-29       Impact factor: 2.374

Review 3.  Label-free molecular imaging of the kidney.

Authors:  Boone M Prentice; Richard M Caprioli; Vincent Vuiblet
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

4.  Using deep Siamese neural networks for detection of brain asymmetries associated with Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Chin-Fu Liu; Shreyas Padhy; Sandhya Ramachandran; Victor X Wang; Andrew Efimov; Alonso Bernal; Linyuan Shi; Marc Vaillant; J Tilak Ratnanather; Andreia V Faria; Brian Caffo; Marilyn Albert; Michael I Miller
Journal:  Magn Reson Imaging       Date:  2019-07-15       Impact factor: 2.546

5.  Multi-auxiliary domain transfer learning for diagnosis of MCI conversion.

Authors:  Bo Cheng; Bingli Zhu; Shuchang Pu
Journal:  Neurol Sci       Date:  2021-09-12       Impact factor: 3.307

6.  Deep residual learning for neuroimaging: An application to predict progression to Alzheimer's disease.

Authors:  Anees Abrol; Manish Bhattarai; Alex Fedorov; Yuhui Du; Sergey Plis; Vince Calhoun
Journal:  J Neurosci Methods       Date:  2020-04-08       Impact factor: 2.390

7.  Transfer learning for predicting conversion from mild cognitive impairment to dementia of Alzheimer's type based on a three-dimensional convolutional neural network.

Authors:  Jinhyeong Bae; Jane Stocks; Ashley Heywood; Youngmoon Jung; Lisanne Jenkins; Virginia Hill; Aggelos Katsaggelos; Karteek Popuri; Howie Rosen; M Faisal Beg; Lei Wang
Journal:  Neurobiol Aging       Date:  2020-12-13       Impact factor: 4.673

8.  Discrimination and conversion prediction of mild cognitive impairment using convolutional neural networks.

Authors:  Congling Wu; Shengwen Guo; Yanjia Hong; Benheng Xiao; Yupeng Wu; Qin Zhang
Journal:  Quant Imaging Med Surg       Date:  2018-11

9.  THAN: task-driven hierarchical attention network for the diagnosis of mild cognitive impairment and Alzheimer's disease.

Authors:  Zhehao Zhang; Linlin Gao; Guang Jin; Lijun Guo; Yudong Yao; Li Dong; Jinming Han
Journal:  Quant Imaging Med Surg       Date:  2021-07

10.  A spatial Bayesian latent factor model for image-on-image regression.

Authors:  Cui Guo; Jian Kang; Timothy D Johnson
Journal:  Biometrics       Date:  2021-01-13       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.